Subscribe To
Why shares of immuneering jumped this week
Immuneering is a clinical-stage biopharmaceutical that focuses on oncology therapies. The company's lea...
March 24, 2023, 1:25 pm
Why is ionis pharmaceuticals (ions) down 8.4% since last earnings report?
Ionis pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock?...
March 24, 2023, 12:59 pm
Impel pharmaceuticals inc. (impl) reports q4 loss, tops revenue estimates
Impel pharmaceuticals Inc. (IMPL) delivered earnings and revenue surprises of 6.73% and 23.35%, respect...
March 24, 2023, 11:27 am
89bio's public stock offering upsized by 38%, priced at a 4% discount
89bio Inc. ETNB, +23.83% said Friday that its public offering of stock, which the biopharmaceutical com...
March 24, 2023, 7:21 am
Gsk says it disagrees with california state court ruling on zantac
U.K. pharmaceutical giant GSK on Friday said it disagreed with a California state court ruling on Zanta...
March 24, 2023, 6:13 am
Aurinia pharmaceuticals: all in on lupkynis - a tough bet
LUPKYNIS has had a lengthy and ultimately productive development pathway. Aurinia has gone all hands on deck to provide LUPKYNIS a successful launch....
March 24, 2023, 12:53 am
Inhibikase therapeutics to report fourth quarter and full-year 2022 financial results on march 31, 2023
BOSTON and ATLANTA , March 23, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage ...
March 23, 2023, 5:15 pm
Tonix pharmaceuticals exec presents data on prader-willi syndrome drug at rare disease conference
Tonix pharmaceuticals (NASDAQ:TNXP) Holding Corp EVP of translation medicine Herbert Harris delivered a...
March 23, 2023, 4:41 pm
Why is apellis pharmaceuticals, inc. (apls) down 7% since last earnings report?
Apellis pharmaceuticals, Inc. (APLS) reported earnings 30 days ago. What's next for the stock?...
March 23, 2023, 12:59 pm
Why moderna wants to raise the cost of its covid-19 vaccine
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss key takeaways from Moderna CEO Stéphane Bancel's testimony before the Senate and why ...
March 23, 2023, 12:00 pm
Regn stock alert: regeneron pharmaceuticals gains on dupixent drug data
Regeneron pharmaceuticals (NASDAQ: REGN ) stock is on the rise Thursday after the company released its ...
March 23, 2023, 10:43 am
Have $1,000? 2 smart stocks to buy this month
Some investors may be feeling uneasy about the state of the stock market, but good values remain. J&J is strong in ...
March 23, 2023, 10:15 am
Should you buy centessa pharmaceuticals (cnta) ahead of earnings?
Centessa pharmaceuticals (CNTA) is seeing favorable earnings estimate revision activity and has a posit...
March 23, 2023, 9:54 am
Why is zyversa therapeutics (zvsa) stock up 35% today?
ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is taking off on Thursday without any recent news from the biopharm...
March 23, 2023, 8:08 am
This is my highest-conviction stock to own in 2023 and beyond
Vertex pharmaceuticals' business is insulated from the effects of economic cycles. The biotech's histor...
March 23, 2023, 7:45 am
Novabay pharmaceuticals to hold 2022 fourth quarter and full year conference call on march 30, 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® pharmaceuticals, Inc. (NYSE American: NBY) announces tha...
March 23, 2023, 6:50 am
Karuna therapeutics to present at the stifel 2023 cns days
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical c...
March 23, 2023, 6:30 am
Nuvalent to present alkove-1 trial in progress poster for nvl-655 at the european lung cancer congress (elcc 2023)
CAMBRIDGE, Mass. , March 23, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceu...
March 23, 2023, 6:30 am
Eli lilly: best-now near-term price gains pharmaceuticals stock
84% of shares held by 3370 “institutional” investors, with over 80% of its $315 Billion market capitalization traded in a year. Not a buy-to-hold ...
March 23, 2023, 12:32 am
Scpharmaceuticals inc. (scph) q4 2022 earnings call transcript
scpharmaceuticals Inc. (NASDAQ:SCPH ) Q4 2022 Earnings Conference Call March 22, 2023 4:30 PM ET Compan...
March 22, 2023, 8:11 pm